Influenza Vaccination Reduces the Risk of Major Cardiovascular Events
Infectious Disease Alert
; 41(10), 2022.
Article
in English
| ProQuest Central | ID: covidwho-1898323
ABSTRACT
The ARR was 4.5% (95% CI, 2.6% to 6.4%;P < 0.001) with an NNT of 23 patients (95% CI, 16-39 patients) to prevent one cardiovascular event. [...]76 of the 4,510 patients (1.7%) who received the influenza vaccine died as a result of cardiovascular causes compared with 111 of the 4,491 patients (2.5%) who received placebo or control within one year of follow-up (RR, 0.74;95% CI, 0.42-1.30), although this result was not statistically significant (P = 0.29). [...]presumably none of the patients with influenza were co-infected with COVID-19, since only one study was conducted during the pandemic (2021). Unfortunately, the vaccine has to be reformulated before each influenza season because of mutations in viral surface proteins. [...]having a universally effective influenza vaccine would be a major advancement.
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Infectious Disease Alert
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS